Welcoming the New Kid on the Block; A Phase IIb Study of DDFPe in Large Vessel Strokes

The latest from NuvOx


- Aug 28, 2019
Dodecafluoropentane Emulsion in Acute Ischemic Stroke: A Phase Ib/II Trial

- Feb 28, 2019
NuvOx Pharma’s NanO2 Shows Positive Results in Phase Ib/II Stroke Trial

- Aug 8, 2016
Dodecafluoropentane Improves Neurological Function Following Anterior Ischemic Stroke

- Oct 31, 2015
DDFPe Extends Window for tPA Therapy in a Rabbit Stroke Model

- Feb 16, 2015
DDFPe delays and reduces MRI markers of infarction in a rat stroke model

- Feb 9, 2015
Multiple Applications of DDFPe Prevents Death in a Rabbit Stroke Model

- Feb 1, 2015
A preliminary PET evaluation of DDFPe effects on rabbit brain hypoxia in stroke

- Dec 30, 2014
DDFPe Decreases Stroke Size and Improves Neurological Scores in a Rat Stroke Model

- Oct 31, 2013
Progress in Dodecafluoropentane Emulsion as a Neuroprotective Agent in a Rabbit Stroke Model

- Nov 12, 2011
Dodecafluoropentane Emulsion Decreases Infarct Volume in a Rabbit Ischemic Stroke Model